Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

v3.7.0.1
Notes Payable (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
May 15, 2017
Feb. 14, 2017
Feb. 10, 2017
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Nov. 14, 2016
Debt Instrument [Line Items]                  
Aggregate additional advances received           $ 97,567 $ 200,000    
Repayment of advances received           4,815 26,910    
Derivative liability       $ 2,904,867   2,904,867   $ 1,583,103  
Accrued purchase obligation       1,200,048   1,200,048      
Debt discount       3,202   3,202   $ 0  
Proceeds from public offering           20,000,000      
Interest expense, net       218,288 $ 35,314 358,949 $ 70,552    
Executive Chairman [Member]                  
Debt Instrument [Line Items]                  
Debt instrument maturity date   May 15, 2017 May 09, 2017            
Principal amount   $ 25,000 $ 22,567 $ 50,000   $ 50,000     $ 410,000
Debt instrument interest rate   10.00% 10.00% 15.00%   15.00%      
Debt conversion price per share       $ 0.70   $ 0.70      
Proceeds from public offering   $ 10,000,000 $ 10,000,000            
Convertible Notes Payable [Member] | Executive Chairman [Member]                  
Debt Instrument [Line Items]                  
Principal amount       $ 545,000   $ 545,000      
Securities and Purchase Agreement [Member]                  
Debt Instrument [Line Items]                  
Debt instrument maturity date Jun. 15, 2017                
Non-assessable origination shares percentage 48.00%                
Warrant to purchase of common stock description (i) $0.70 per share, or (ii) the lowest daily closing price of the Common Stock during the ten days prior to delivery of the Origination Shares (subject to adjustment for stock splits), or (iii) 80% of the Common Stock offering price of the public offering, or (iv) 80% of the unit price offering price of the public offering (if applicable), or (v) the exercise price of any warrants issued in the public offering.                
Number of shares of common stock outstanding percentage 9.99%                
Principal amount $ 96,435                
Number of warrant to purchase of common stock shares       2,142,998   2,142,998      
Warrant term           5 years      
Derivative liability       $ 74,392   $ 74,392      
Aggregate exercise price of warrants           1,500,100      
Placement agent fees and other issuance costs           1,550,977      
Accrued purchase obligation       1,200,048   1,200,048      
Debt discount       54,322   54,322      
Debt discount recognized over the term value       $ 1,496,654   1,496,654      
Securities and Purchase Agreement [Member] | Purchaser [Member]                  
Debt Instrument [Line Items]                  
Aggregate additional advances received           2,500,100      
Repayment of advances received           1,596,535      
Securities and Purchase Agreement [Member] | Promissory Note [Member]                  
Debt Instrument [Line Items]                  
Aggregate additional advances received           $ 1,500,100